Microsaic Systems (MET) AI Stock Analysis

• Market Cap: £3.21M
• Dividend Yield: N/A
• Average Volume (3M): 680.45K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.46
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: UK
• Employees: 4
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): >-0.01
• Shares Outstanding: 443,239,500
• 10 Day Avg. Volume: 260,647
• 30 Day Avg. Volume: 680,450
• PEG Ratio: <0.01
• Price to Book (P/B): 7.27
• Price to Sales (P/S): 5.77
• P/FCF Ratio: -0.72
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: 0.88p ▼(-2.00% Downside)
• Action: N/A Date: 01/20/26
• Date: Action: N/A 01/20/26

The score is primarily weighed down by very weak financial performance: sharp revenue contraction, negative margins, ongoing losses, and significant cash burn, despite low debt. Technicals provide some offset with positive trend/momentum, but overbought signals temper that support. Valuation is neutral due to missing P/E and dividend yield data.

Positive Factors

Low leverage reduces near-term financing risk

Very low debt materially limits interest burden and reduces near-term refinancing pressure, giving management flexibility to prioritize product development or customer support. This structural balance-sheet cushion lowers default risk and supports strategic options over the next several months.

Product + recurring service revenue model

A hardware business with an attached service/maintenance revenue stream creates durable aftermarket income potential. If the installed base grows, recurring service contracts can stabilize cash flows and improve lifetime customer value, supporting longer-term revenue resilience.

Evidence of operational improvement vs prior year

Narrowing losses and reduced free cash outflow versus the prior year indicate management is making progress on cost control or revenue levers. A consistent improvement trend is a durable positive, improving runway and credibility for execution over the next 2-6 months.

Negative Factors

Sharp revenue contraction

A ~53% revenue decline signals severe demand, sales execution, or market penetration issues. Sustained top-line shrinkage undermines scale economics, reduces installed-base growth for aftermarket sales, and makes margin recovery and cash self-sufficiency much harder.

Negative gross profit and heavy net losses

Negative gross profit indicates core product economics are currently unprofitable—likely due to high unit costs, pricing pressure, or low volume. Persistent deep losses erode equity, hinder reinvestment, and require structural changes to restore sustainable margins.

Significant operating cash burn

Material negative operating and free cash flow relative to a small revenue base creates ongoing funding needs. Continued cash burn forces reliance on external financing or dilutive measures, constraining R&D, sales investment, and the ability to scale the business sustainably.

Microsaic Systems Business Overview & Revenue Model

Company Description

Metir plc manufactures and sells equipment used monitoring water for toxins and pathogens in the United Kingdom, the United States, Europe, China, and internationally. The company provides compact mass spectrometers and the Modern Water MicroTox CTM, FX, and LX toxicity monitors; consumables and spare parts; toxicity monitoring in water; and point-of-need contaminant detection, as well as support and consultancy services. It sells its products through OEMs and distribution sales channels. The company was formerly known as Microsaic Systems plc and changed its name to Metir plc in February 2025. Metir plc was incorporated in 1998 and is based in York, the United Kingdom.

How the Company Makes Money

Microsaic Systems Financial Statement Overview

Summary

Operating fundamentals are very weak: revenue fell sharply (~53% YoY) to a very small base, gross profit turned negative, and net income remained deeply negative (-1.81m). Cash flow is also concerning with continued operating cash burn (-1.66m) and negative free cash flow (-1.86m). A mitigating factor is low leverage (minimal debt) and some improvement versus 2023 in losses and free cash outflow, but overall execution and funding risk remains elevated.

Income Statement

Profitability is very weak: 2024 revenue fell sharply to 232k (down ~53% YoY) and gross profit turned negative, indicating the core product/service economics deteriorated. Losses remain large relative to sales, with net income at -1.81m and deeply negative margins, showing the business is still far from operating leverage. A modest positive is that the absolute net loss narrowed versus 2023, but the trajectory is dominated by shrinking revenue and persistently heavy losses.

Balance Sheet

Leverage is low, with only 19k of total debt against 184k of equity in 2024, which reduces near-term financial risk and interest burden. However, equity has declined materially versus prior years (reflecting ongoing losses), and returns on equity are strongly negative, signaling value erosion. Overall, the balance sheet is not debt-stressed, but it is weakening as losses continue.

Cash Flow

Cash generation is poor: 2024 operating cash flow was -1.66m and free cash flow was -1.86m, implying continued cash burn to fund operations and investment needs. Free cash flow improved versus 2023 (less negative), but it remains deeply negative and still larger in magnitude than net losses, highlighting ongoing funding requirements. The trend is slightly better, but sustainability is still a key concern.

Breakdown	TTM	Dec 2024	Jun 2024	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	492.00K	232.00K	492.00K	1.57M	906.88K	198.26K
Gross Profit	159.97K	-125.00K	13.00K	949.37K	380.65K	99.91K
EBITDA	-2.72M	-1.76M	-2.31M	-2.25M	-3.19M	-2.37M
Net Income	-2.60M	-1.81M	-2.60M	-2.29M	-3.13M	-2.37M
Balance Sheet
Total Assets	713.00K	1.40M	713.00K	3.13M	5.16M	1.61M
Cash, Cash Equivalents and Short-Term Investments	173.00K	188.00K	173.00K	1.24M	3.46M	397.07K
Total Debt	21.00K	19.00K	21.00K	56.25K	127.34K	53.47K
Total Liabilities	569.00K	1.22M	569.00K	408.08K	581.92K	363.43K
Stockholders Equity	144.00K	184.00K	144.00K	2.72M	4.57M	1.24M
Cash Flow
Free Cash Flow	-1.05M	-1.85M	-1.07M	-2.34M	-1.94M	-2.13M
Operating Cash Flow	-1.04M	-1.66M	-1.06M	-2.13M	-1.60M	-2.03M
Investing Cash Flow	35.00K	-175.00K	48.00K	-211.95K	-334.22K	-96.77K
Financing Cash Flow	-59.00K	1.84M	-59.00K	121.89K	5.01M	-97.41K

Microsaic Systems Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
TIDE	58 Neutral	£5.92M	―	―	―	―	―
MET	46 Neutral	£3.21M	―	―	―	―	―
AIQ	45 Neutral	£2.59M	-5.87	―	―	-47.47%	12.50%
CTAI	42 Neutral	£2.94M	-3.81	-42.53%	―	―	―
RDT	40 Underperform	£2.15M	-0.28	-213.44%	―	5.29%	72.50%

Microsaic Systems Corporate Events

Metir boosts revenue tenfold as demand outstrips manufacturing capacity

Metir reported that trading for the year to 31 December 2025 was in line with expectations, with revenues expected to rise sharply to £1.5m from £0.23m, driven by strong international demand for its Microtox instruments and reagents, robust interest in relaunched sulphate-reducing bacteria test kits, and progress on large potable water monitoring projects such as the continuous toxic monitoring installation in Qatar. While outsourced manufacturing constraints in the fourth quarter limited the conversion of orders into revenue and delayed shipment of some Microtox units into early 2026, the company has reinforced its balance sheet with a £1m fundraising to expand production capacity, unlock higher-margin recurring reagent sales and advance new technologies including mobile PFAS and real-time pathogen detection, which the board believes will support near-term growth, margin improvement and a path towards sustainable profitability.

Metir raises £1m to accelerate water testing growth and bolster working capital

Metir plc has completed a placing of 133,333,333 new shares at 0.75p to raise up to £1m before expenses, alongside an equal number of investor warrants exercisable at 1.5p, to strengthen its working capital and support accelerated growth towards profitability. The funds will be used to increase production capacity for its Microtox instruments and SRB kits, build inventory to convert a growing order book into revenue, scale 24/7 continuous toxic monitoring deployments such as its Qatar project, further develop CTM software and PFAS technologies, and invest in sales, marketing and distribution infrastructure, while leaving the company with an expected net cash position of about £1.09m and adequate working capital. The placing shares, representing around 30% of the enlarged share capital, are expected to be admitted to trading on AIM on or around 24 December 2025, with director Nigel Burton participating as a related party on the same terms as other investors, a move the independent board members deem fair and reasonable for shareholders.

Metir plc Reports Strong Demand and Strategic Growth Plans for 2026

Metir plc, a leader in water and environmental testing technology, reports strong demand for its Microtox® LX instruments and SRB kits, with sales aligning with management expectations. The company is nearing its manufacturing capacity limits and is in discussions to increase production in 2026 to meet growing demand. Metir’s growth strategy includes upgrading its LX and FX units and expanding its presence in the GCC region, particularly in Qatar and Saudi Arabia, to capitalize on large-scale water safety projects. The company is investing in manufacturing and product development to support long-term growth, with 2026 expected to be a transformational year.

Metir plc Strengthens Leadership and Business Development for Global Expansion

Metir plc has announced the appointment of Claire Smith as Chief Financial Officer, along with new hires to enhance its business development team. These strategic appointments aim to accelerate the company’s growth in the UK and internationally by expanding its distributor network and enhancing customer engagement. The new business development function will focus on driving sales of Metir’s product lines and increasing recurring revenue, ultimately strengthening the company’s market position and delivering long-term shareholder value.

Metir and Swansea University Advance PFAS Detection Technology

Metir plc, in collaboration with Swansea University, has advanced its ‘Lab in a Van’ solution for detecting PFAS chemicals, positioning itself at the forefront of sustainable environmental monitoring amid increasing regulatory scrutiny. This innovation, which integrates portable liquid chromatography-mass spectrometry with low-waste materials, enables rapid and accurate on-site detection of PFAS, significantly reducing analysis time and environmental impact. Successful field trials in Wales and ongoing collaboration with a US partner highlight the technology’s potential for commercial deployment, particularly in the US market, helping regulators and industries meet stringent environmental standards and enhance public health protection.